BSETrident Texofab LtdMediumNeutral
Announced Mon, 12 May · 21:14 IST

Outcome of Board Meeting of the Company held on Monday, May 12, 2025 for Conversion of 4,08,333 warrants into 4,08,333 equity shares of face value of Rs. 10/- each.

Warrants ConvertedFund Raising View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Trident Texofab's Board, on May 12, 2025, approved the conversion of 4,08,333 warrants into an equal number of equity shares at Rs. 70 each (face value Rs. 10 plus a Rs. 60 premium). The company received Rs. 2.14 crore as the remaining 75% payment from 17 allottees under the Non-Promoter, Public Category. This is part of the original 58,37,143 warrants allotted on a preferential basis on December 23, 2024. After this conversion, the company's paid-up equity capital rose to Rs. 13.97 crore, comprising 1,39,67,093 shares. Around 19.40 lakh warrants are still outstanding and eligible for conversion within 18 months. The Board also cleared a Postal Ballot to appoint Mr. Katwala Sandip Jayeshkumar as a Non-Executive Independent Director.

Likely market impact

This is a small equity dilution of about 4.08 lakh shares, with roughly 19.4 lakh more warrants still pending conversion, which could add further dilution in coming months. Existing shareholders may see a minor reduction in their proportional ownership, though the Rs. 2.14 crore raised strengthens the company's equity base modestly.